Arboretum LifeSciences raises $30M in Series A funding to enhance scientific infrastructure and accelerate genetic testing adoption.
Amount Raised
$30 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareMedicalGeneticsHealth DiagnosticsInvestors
Description
Arboretum LifeSciences, based in Cambridge, MA, raised $30M in Series A financing. The funding will be used to build scientific and operational infrastructure, expand product development, and scale its molecular research network. Backers included F-Prime, GV, and .406 Ventures. The company focuses on integrating AI with genetic testing for common diseases.
Quick answer
Arboretum LifeSciences raised $30 Million in a Series A round, dated October 7, 2026. Investors: Amgen, Hims & Hers, .406 Ventures, GV and F Prime. Arboretum LifeSciences is based in Cambridge, Massachusetts, United States.
- How much did Arboretum LifeSciences raise?
- Arboretum LifeSciences raised $30 Million in a Series A round on October 7, 2026.
- Who invested in Arboretum LifeSciences?
- Amgen, Hims & Hers, .406 Ventures, GV and F Prime are named as investors in this round.
- What does Arboretum LifeSciences do?
- Arboretum LifeSciences is a molecular information company based in Cambridge, MA.
- Where is Arboretum LifeSciences based and how big is it?
- Arboretum LifeSciences is based in Cambridge, Massachusetts, United States. Fundz records about 12 employees.
- Who are the decision-makers at Arboretum LifeSciences?
- Fundz holds 2 contacts at Arboretum LifeSciences, including the Senior Director Corporate Strategy and Finance. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Genetics around the same time
Companies in the same sectors as Arboretum LifeSciences that raised within 45 days of this round, from Fundz verified event records.
- Alterra Labs raised $13M (Seed) on November 10, 2026.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
- Coherence Neuro raised $45M (Series A) on October 22, 2026.
- BioStack raised $9.5M (Seed) on October 22, 2026.
- MintNeuro raised $5M on October 7, 2026.
Who to call at Arboretum LifeSciences, and when
A new round usually means Arboretum LifeSciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Arboretum LifeSciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arboretum LifeSciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arboretum LifeSciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arboretum LifeSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansArboretum LifeSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.